Discoveries/FEDRATINIB

✓ X-VAULT VERIFIEDPRIORITY SIGNALNOVELTY: EXCEPTIONAL

FEDRATINIB

Hemostasis candidate

210111.2

discovery score

PubMed Studies

Novelty

Exceptional

Tier

Priority Signal

Sealed

Mar 8, 2026

BiohacksAI Hypothesis

Fedratinib may modulate the Hemostasis pathway based on its molecular target profile in the BiohacksAI corpus. This compound shows biological activity against validated targets with limited prior literature coverage, suggesting an understudied mechanism-of-action with potential research value.

This is a computational hypothesis based on target graph analysis. Not a confirmed mechanism. Independent experimental validation required.

Mechanism Discovery Graph

High-value target (Tier 3)

Research target (Tier 2)

Standard target

Pathway

Knowledge gap (≤5 studies)

Biological Plausibility

The Hemostasis pathway is a validated biological target area with established relevance in human disease and health optimization research.

Fedratinib shows target overlap with compounds previously characterized in this pathway within the BiohacksAI corpus of 9,238 graph entities and 1.12M PubMed studies.

Low literature coverage (0 studies) relative to target engagement indicates this mechanism may be undercharacterized in current scientific literature — a signal consistent with early-stage discovery candidates.

Novelty Indicators

Literature coverage

0 PubMed studies

Low coverage = higher novelty potential

Discovery score

210111.22

target_count × pathway_diversity / log(studies + 2)

Mechanism area

Hemostasis

Primary biological pathway

Novelty rating

Exceptional

Derived from score + literature coverage

Research Context

◈

Literature coverage

0 PubMed studies indexed at time of discovery

◈

X-Vault timestamp

Sealed Mar 8, 2026 — cryptographic proof of discovery date and corpus version

◈

Corpus scope

BiohacksAI corpus only — not a comprehensive literature or patent database search

◈

Mechanism area

Hemostasis — computationally derived, requires experimental confirmation

This section reflects computational signal strength only. BiohacksAI does not perform patent searches or legal IP analysis. All findings require independent expert validation before any commercial or research use.

Suggested Validation Steps

1Platelet aggregation assay

2Coagulation factor activity panel

3Thrombin generation test

4Bleeding time model (in vivo)

Validation roadmap is algorithmically derived from pathway context. Full experimental protocol available in Priority Signal discovery reports.

Discovery Lineage

Generated byBiohacksAI Discovery Engine

Engine versionDISCOVERY_v1.0

Corpus versionv20260307-01

Graph entities9,238 compounds analyzed

PubMed coverage1,120,000+ studies

Discovery dateMarch 8, 2026 at 01:00 PM UTC

X-Vault Evidence SealXVAULT_v1

Discovery IDDISC-fedratinib-20260308-7eb856f4

Event Hash01c4362b5bd89098…3d4e0b1d

Chain Hashd9ac1807662c89ff…a7a65224

Vault Index#6

Sealed At2026-03-08T13:00:35.096Z

Verify this discovery →eveverified.com/verify

Full Discovery ReportLOCKED

🔒

Mechanism hypothesis (expanded)

Detailed molecular mechanism with target confidence scores and binding context

🔒

Complete target mapping

All validated molecular targets with affinity data and evidence levels

🔒

Biological pathway network

Full pathway coverage map with crosstalk and downstream effects

🔒

Graph position + related compounds

Structural neighbors in the BiohacksAI compound graph — potential analogs

🔒

Supporting PMIDs

Curated PubMed references with relevance ranking

🔒

X-Vault sealed PDF

Cryptographically verified 20-30 page discovery report

🔒

Signed license agreement

Legal document with IP terms, royalty clause, and X-Vault seal reference

Purchase License

Unlocks full discovery report, PDF, and signed license agreement within 24 hours.

SHARED RESEARCH LICENSE

$999

✓ Full discovery report PDF
✓ X-Vault seal + verification link
✓ Research & publication rights
✓ 10% royalty share if IP is commercialised
BiohacksAI retains 90% IP · Multiple buyers

Purchase Shared License — $999

EXCLUSIVE LICENSE

$24,900

✓ Everything in Shared
✓ Commercial rights
✓ One buyer — exclusivity guaranteed
✓ 90% IP transferred to buyer
BiohacksAI retains 10% royalty on commercialisation

Purchase Exclusive License — $24,900

All discoveries are computational hypothesis candidates — not confirmed mechanisms. Patent eligibility must be independently assessed by qualified counsel. X-Vault seals provide cryptographic proof of discovery timestamp and corpus version. Organiq Sweden AB · BiohacksAI β